Advisory Firms Recommend Bausch Shareholders Approve AMO Sale

Eye-care products maker Bausch & Lomb said Friday that four proxy advisory firms have recommended that shareholders approve the $3.67 billion sale of the company to private equity firm Warburg Pincus. In August, Bausch & Lomb (up $0.11 to $63.31, Charts) asked shareholders to approve the sale. A special shareholder meeting is scheduled for Sept. 21 to vote on the matter. Video More video The latest in business news with the CNN.com business bulletin. Play video In a statement, the company said Institutional Shareholder Services, Egan-Jones Proxy Services, Glass Lewis, and Proxy Governance recommended the sale. In May, Bausch & Lomb entered into an agreement with Warburg Pincus to sell the company at $65 per share in cash, or about $3.67 billion, plus $830 million in assumed debt. In July, Advanced Medical Optics (Charts) made an unsolicited counter bid for $4.2 billion, or $45 per share in cash and $30 in stock, but withdrew the offer last month.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters